GRP
TAK icon

Global Retirement Partners’s Takeda Pharmaceutical TAK Stock Holding History

Global Retirement Partners’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$619K Buy
+38,613
New +$639K 0.01% 932
2025
Q4 		$503K Buy
32,238
+22,934
+246% +$328K 0.01% 958
2025
Q3 		$136K Sell
9,304
-41,170
-82% -$611K ﹤0.01% 1367
2025
Q2 		$780K Buy
+50,474
New +$746K 0.02% 571
2024
Q4 		$7.36K Sell
556
-2,617
-82% -$35.9K ﹤0.01% 2516
2024
Q3 		$45.1K Sell
3,173
-2,972
-48% -$42.2K ﹤0.01% 1610
2024
Q2 		$79.5K Buy
6,145
+153
+3% +$2.03K ﹤0.01% 1311
2024
Q1 		$83.2K Sell
5,992
-145
-2% -$2.11K ﹤0.01% 1164
2023
Q4 		$92.1K Buy
6,137
+22
+0.4% +$312 ﹤0.01% 1087
2023
Q3 		$89.5K Buy
6,115
+128
+2% +$1.98K ﹤0.01% 983
2023
Q2 		$94K Buy
5,987
+297
+5% +$4.87K ﹤0.01% 972
2023
Q1 		$95.1K Buy
5,690
+1,535
+37% +$24.5K 0.01% 946
2022
Q4 		$64.8K Sell
4,155
-1,113
-21% -$15.5K ﹤0.01% 981
2022
Q3 		$70K Sell
5,268
-1,151
-18% -$16K 0.01% 892
2022
Q2 		$90K Sell
6,419
-1,169
-15% -$16.7K 0.01% 787
2022
Q1 		$113K Buy
+7,588
New +$111K 0.01% 719
2021
Q4 		– Sell
-5,187
Closed -$85K – 1619
2021
Q3 		$85K Buy
5,187
+110
+2% +$1.85K 0.01% 697
2021
Q2 		$85K Buy
5,077
+745
+17% +$12.7K 0.01% 680
2021
Q1 		$79K Hold
4,332
– – 0.01% 636
2020
Q4 		$79K Buy
4,332
+451
+12% +$7.91K 0.01% 588
2020
Q3 		$69K Buy
3,881
+226
+6% +$4.12K 0.01% 567
2020
Q2 		$66K Buy
3,655
+283
+8% +$5.08K 0.01% 573
2020
Q1 		$51K Hold
3,372
– – 0.01% 559
2019
Q4 		$67K Sell
3,372
-264
-7% -$5.05K 0.01% 570
2019
Q3 		$63K Buy
3,636
+4
+0.1% +$69 0.01% 570
2019
Q2 		$64K Buy
3,632
+211
+6% +$3.84K 0.01% 556
2019
Q1 		$70K Buy
3,421
+1,326
+63% +$26.7K 0.02% 463
2018
Q4 		$35K Buy
+2,095
New +$35.4K 0.01% 602

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Global Retirement Partners's TAK Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 38,613 shares worth $619K. The stake represents 0.01% of the portfolio and ranks #932 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TAK as recently as Q4 2025.

Global Retirement Partners first reported a position in TAK in Q4 2018 and has held it in 28 quarters since. The position peaked at $780K in Q2 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Global Retirement Partners held 38,613 shares of Takeda Pharmaceutical worth $619K as of Q2 2026.
  • Takeda Pharmaceutical was a new Global Retirement Partners position in Q2 2026.
  • Takeda Pharmaceutical made up 0.01% of Global Retirement Partners's portfolio in Q2 2026, its #932 holding.
  • Global Retirement Partners first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 28 quarters since.
  • Global Retirement Partners's Takeda Pharmaceutical position peaked at $780K in Q2 2025.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.